Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener
Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2019-08-19 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $6.03 | -100,000 | 1,564,330 | -6% | -$603,360 | |||||
2019-08-20 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $64.50 | -900 | 7,342,784 | 0% | -$58,050 | ||||||
| D | 2019-08-16 | EXEL | Exelixis, Inc. | Hessekiel Jeffrey | EVP, GC | S - Sale+OE | $21.10 | -75,000 | 234,819 | -24% | -$1,582,500 | |||||
2019-08-19 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $2.19 | +16,000 | 126,619 | +14% | +$35,040 | ||||||
| D | 2019-08-16 | EXEL | Exelixis, Inc. | Poste George | Dir | S - Sale+OE | $20.50 | -25,000 | 112,792 | -18% | -$512,500 | |||||
2019-08-19 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $64.68 | -12,198 | 7,343,684 | 0% | -$788,943 | ||||||
| D | 2019-08-15 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $80.96 | -2,500 | 41,612 | -6% | -$202,400 | |||||
2019-08-16 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $64.74 | -3,763 | 7,355,882 | 0% | -$243,623 | ||||||
| D | 2019-08-14 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $20.11 | -35,040 | 376,795 | -9% | -$704,654 | |||||
| M | 2019-08-14 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.58 | -79,305 | 1,664,330 | -5% | -$442,896 | |||||
| M | 2019-08-14 | NRC | National Research Corp | Amandla Mk Trust | 10% | S - Sale | $64.72 | -19,000 | 7,359,645 | 0% | -$1,229,672 | |||||
2019-08-12 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $20.39 | -1,000 | 120,640 | -1% | -$20,390 | ||||||
| M | 2019-08-12 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.64 | -120,695 | 1,743,635 | -6% | -$680,414 | |||||
| D | 2019-08-12 | CRL | Charles River Laboratories International, Inc. | Smith David Ross | Corporate EVP, CFO | S - Sale+OE | $130.36 | -1,249 | 18,078 | -6% | -$162,821 | |||||
2019-08-08 | IQV | Iqvia Holdings Inc. | Tpg Group Holdings (Sbs) Advisors, Inc. | Dir | S - Sale | $156.85 | -2,616,028 | 5,915,223 | -31% | -$410,323,992 | ||||||
2019-08-08 | IQV | Iqvia Holdings Inc. | Connaughton John | Dir | S - Sale | $156.85 | -573,085 | 1,389,540 | -29% | -$89,888,382 | ||||||
| D | 2019-08-09 | EXEL | Exelixis, Inc. | Poste George | Dir | S - Sale+OE | $20.60 | -20,000 | 112,792 | -15% | -$412,000 | |||||
2019-08-08 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.25 | -54,495 | 1,864,330 | -3% | -$286,099 | ||||||
| D | 2019-08-06 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale+OE | $20.02 | -25,000 | 121,640 | -17% | -$500,500 | |||||
2019-08-06 | BUDZ | Weed, Inc. | Kwestel Elliot | Dir | S - Sale | $0.51 | -10,000 | 118,000 | -8% | -$5,095 | ||||||
| DM | 2019-08-02 | INCY | Incyte Corp | Friedman Paul A | Dir | S - Sale+OE | $82.69 | -100,000 | 315,531 | -24% | -$8,268,766 | |||||
2019-08-01 | IQV | Iqvia Holdings Inc. | Knightly Kevin C | See Remarks | S - Sale | $158.50 | -4,278 | 4,084 | -51% | -$678,063 | ||||||
| M | 2019-08-01 | INCY | Incyte Corp | Bienaime Jean Jacques | Dir | S - Sale | $85.07 | -1,724 | 7,055 | -20% | -$146,654 | |||||
| D | 2019-08-02 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $20.25 | -35,040 | 361,835 | -9% | -$709,560 | |||||
2019-08-01 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $20.59 | -40,000 | 1,151,626 | -3% | -$823,738 | ||||||
| M | 2019-07-31 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.34 | -45,505 | 1,918,825 | -2% | -$243,121 | |||||
2019-07-31 | EXAS | Exact Sciences Corp | Zanotti Katherine S | Dir | S - Sale | $117.93 | -1,744 | 77,513 | -2% | -$205,670 | ||||||
| D | 2019-07-31 | EXAS | Exact Sciences Corp | Wyzga Michael S | Dir | S - Sale+OE | $117.93 | -5,000 | 8,913 | -36% | -$589,650 | |||||
| D | 2019-07-31 | EXAS | Exact Sciences Corp | Levangie Daniel J | Dir | S - Sale+OE | $117.64 | -42,607 | 12,458 | -77% | -$5,012,398 | |||||
2019-07-31 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $117.93 | -2,808 | 34,440 | -8% | -$331,147 | ||||||
2019-07-31 | EXAS | Exact Sciences Corp | Carey Thomas D. | Dir | S - Sale | $117.65 | -10,000 | 34,181 | -23% | -$1,176,487 | ||||||
| D | 2019-07-30 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale+OE | $105.60 | -9,845 | 50,877 | -16% | -$1,039,632 | |||||
2019-07-29 | IQV | Iqvia Holdings Inc. | Knightly Kevin C | See Remarks | S - Sale | $158.53 | -6,945 | 8,362 | -45% | -$1,100,991 | ||||||
| M | 2019-07-26 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.01 | -24,332 | 1,964,330 | -1% | -$122,004 | |||||
| M | 2019-07-24 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.00 | -14,579 | 1,988,662 | -1% | -$72,895 | |||||
| M | 2019-07-22 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.02 | -93,550 | 2,003,241 | -4% | -$469,565 | |||||
| M | 2019-07-18 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.00 | -47,404 | 2,096,791 | -2% | -$237,020 | |||||
| M | 2019-07-12 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.57 | -33,350 | 23,834,949 | 0% | -$19,143 | |||||
| M | 2019-07-01 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.54 | -33,000 | 23,868,299 | 0% | -$17,850 | |||||
| M | 2019-06-20 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.60 | -41,000 | 23,901,299 | 0% | -$24,642 | |||||
| D | 2019-07-17 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $21.37 | -34,721 | 346,875 | -9% | -$741,988 | |||||
| D | 2019-07-18 | XON | Intrexon Corp | Sabzevari Helen | Pres, Precigen, Inc. | S - Sale+OE | $7.47 | -8,484 | 62,341 | -12% | -$63,377 | |||||
2019-07-17 | INCY | Incyte Corp | Flannelly Barry P | EVP, GM US | S - Sale | $79.91 | -959 | 19,248 | -5% | -$76,634 | ||||||
| M | 2019-07-16 | LUNA | Luna Innovations Inc | Carilion Clinic | 10% | S - Sale | $5.02 | -20,135 | 2,144,195 | -1% | -$101,021 | |||||
| D | 2019-07-15 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $80.00 | -2,500 | 41,612 | -6% | -$200,000 | |||||
2019-07-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $20.96 | -1,000 | 121,640 | -1% | -$20,960 | ||||||
2018-08-03 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $38.00 | -3,491 | 4,751,522 | 0% | -$132,658 | ||||||
2019-07-01 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $21.58 | -40,000 | 1,191,626 | -3% | -$863,200 | ||||||
| D | 2019-07-03 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $21.03 | -34,721 | 331,596 | -9% | -$730,183 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Walsh Robert F. III | SVP, Energy, Fine Chem. | S - Sale+OE | $7.76 | -5,007 | 28,816 | -15% | -$38,854 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Sterling Rick L. | CFO | S - Sale+OE | $7.76 | -4,359 | 104,629 | -4% | -$33,826 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Sabzevari Helen | Pres, Precigen, Inc. | S - Sale+OE | $7.76 | -4,822 | 45,825 | -10% | -$37,419 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Reed Thomas D. | Chief Science Officer | S - Sale+OE | $7.76 | -3,527 | 214,079 | -2% | -$27,370 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Perez Jeffrey Thomas | SVP, IP Affairs | S - Sale+OE | $7.76 | -4,359 | 42,545 | -9% | -$33,826 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Lehr Donald P. | GC | S - Sale+OE | $7.76 | -4,822 | 57,476 | -8% | -$37,419 | |||||
| D | 2019-07-01 | XON | Intrexon Corp | Bostick Thomas | COO | S - Sale+OE | $7.76 | -4,359 | 35,877 | -11% | -$33,826 | |||||
| D | 2019-06-28 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $160.00 | -96,000 | 1,273,439 | -7% | -$15,360,000 | |||||
2019-06-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Nussbaum Ran | Dir | P - Purchase | $9.00 | +200,000 | 7,212,186 | +3% | +$1,800,000 | ||||||
2019-06-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Kariv Tomer | Dir | P - Purchase | $9.00 | +200,000 | 7,212,186 | +3% | +$1,800,000 | ||||||
2019-06-24 | ELOX | Eloxx Pharmaceuticals, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% | P - Purchase | $9.00 | +200,000 | 24,000 | -114% | +$1,800,000 | ||||||
| M | 2019-06-12 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.63 | -32,000 | 23,942,299 | 0% | -$20,071 | |||||
| M | 2019-05-24 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.68 | -40,054 | 23,974,299 | 0% | -$27,336 | |||||
2019-06-24 | INCY | Incyte Corp | Stein Steven H | EVP, Chief Medical Officer | S - Sale | $87.96 | -8,357 | 10,805 | -44% | -$735,082 | ||||||
| D | 2019-06-19 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $150.00 | -96,000 | 1,273,439 | -7% | -$14,400,000 | |||||
| DM | 2019-06-17 | EXEL | Exelixis, Inc. | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.59 | -217,404 | 134,302 | -62% | -$4,477,307 | |||||
| D | 2019-06-17 | INCY | Incyte Corp | Swain Paula J | EVP, HR | S - Sale+OE | $80.00 | -2,500 | 36,513 | -6% | -$200,000 | |||||
| D | 2019-06-13 | EXEL | Exelixis, Inc. | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.03 | -27,596 | 134,302 | -17% | -$552,748 | |||||
2019-06-13 | BASI | Bioanalytical Systems Inc | Neff R Matthew | Dir | P - Purchase | $1.98 | +1,410 | 22,125 | +7% | +$2,792 | ||||||
| M | 2019-06-12 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $1.97 | +5,004 | 110,619 | +5% | +$9,858 | |||||
2019-06-14 | BASI | Bioanalytical Systems Inc | Oakley Daniel Thomas | COO | P - Purchase | $1.99 | +7,500 | 28,452 | +36% | +$14,925 | ||||||
2019-06-11 | BASI | Bioanalytical Systems Inc | Blumhoff Jill | VP, Finance, CFO | P - Purchase | $1.98 | +500 | 1,811 | +38% | +$990 | ||||||
2019-06-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $20.23 | -1,000 | 122,640 | -1% | -$20,230 | ||||||
2019-06-10 | BASI | Bioanalytical Systems Inc | Downing Philip A | SVP, Preclinical Srvcs. | P - Purchase | $1.96 | +5,000 | 25,765 | +24% | +$9,800 | ||||||
| M | 2019-06-06 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $5.24 | +322,179 | 50,397,399 | +1% | +$1,689,443 | |||||
| M | 2019-06-06 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $5.24 | +483,268 | 23,980,893 | +2% | +$2,534,162 | |||||
| M | 2019-06-06 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $1.96 | +6,000 | 105,615 | +6% | +$11,750 | |||||
| M | 2019-06-03 | EXEL | Exelixis, Inc. | Scangos George A | Dir | S - Sale | $19.76 | -40,000 | 1,231,626 | -3% | -$790,250 | |||||
| M | 2019-05-31 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.91 | +135,548 | 47,799,190 | 0% | +$665,516 | |||||
| M | 2019-05-31 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.91 | +203,321 | 25,773,655 | +1% | +$998,269 | |||||
| M | 2019-05-29 | BASI | Bioanalytical Systems Inc | Davis Gregory Cole | Dir | P - Purchase | $1.98 | +15,000 | 20,000 | +300% | +$29,750 | |||||
| M | 2019-05-29 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.75 | +330,180 | 49,754,783 | +1% | +$1,567,799 | |||||
| M | 2019-05-29 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.75 | +495,271 | 23,250,021 | +2% | +$2,351,703 | |||||
2019-05-29 | CRL | Charles River Laboratories International Inc | Barbo William D | Corporate EVP, CCO | S - Sale | $125.96 | -1,253 | 19,701 | -6% | -$157,830 | ||||||
| D | 2019-05-29 | CRL | Charles River Laboratories International Inc | Barbo William D | Corporate EVP, CCO | S - Sale+OE | $125.16 | -4,905 | 20,954 | -19% | -$613,919 | |||||
| M | 2019-05-22 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.69 | +273,367 | 49,424,603 | +1% | +$1,280,804 | |||||
| M | 2019-05-22 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.69 | +410,050 | 22,754,750 | +2% | +$1,921,203 | |||||
| M | 2019-05-17 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.65 | +422,423 | 49,151,236 | +1% | +$1,966,075 | |||||
| M | 2019-05-17 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.65 | +633,631 | 22,344,700 | +3% | +$2,949,096 | |||||
| M | 2019-05-03 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.82 | -15,474 | 24,014,353 | 0% | -$12,744 | |||||
| M | 2019-04-02 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.96 | -58,821 | 24,029,827 | 0% | -$56,234 | |||||
2019-05-15 | CRL | Charles River Laboratories International Inc | Massaro George | Dir | S - Sale | $131.38 | -1,002 | 10,202 | -9% | -$131,643 | ||||||
| M | 2019-05-13 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.40 | +838,482 | 48,728,813 | +2% | +$3,688,026 | |||||
| M | 2019-05-13 | XON | Intrexon Corp | Kirk Randal J | CEO, 10% | P - Purchase | $4.40 | +1,257,727 | 21,711,069 | +6% | +$5,532,056 | |||||
| D | 2019-05-10 | CRL | Charles River Laboratories International Inc | Massaro George | Dir | S - Sale+OE | $134.64 | -3,140 | 12,204 | -20% | -$422,769 | |||||
2019-05-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $19.58 | -1,000 | 123,640 | -1% | -$19,580 | ||||||
| D | 2019-05-08 | EXEL | Exelixis, Inc. | Morrissey Michael | Pres, CEO | S - Sale+OE | $20.15 | -42,000 | 301,726 | -12% | -$846,300 | |||||
2019-05-08 | EXEL | Exelixis, Inc. | Willsey Lance | Dir | S - Sale | $20.36 | -50,000 | 368,273 | -12% | -$1,018,000 | ||||||
2019-05-08 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.00 | -185,088 | 4,755,013 | -4% | -$7,403,668 | ||||||
| M | 2019-05-06 | NRC | National Research Corp | K/i/e Trust Under Agreement 10/24/18 | 10% | S - Sale | $40.01 | -49,266 | 4,940,101 | -1% | -$1,970,979 | |||||
| D | 2019-05-03 | IQV | Iqvia Holdings Inc. | Knightly Kevin C | See Remarks | S - Sale+OE | $138.06 | -46,080 | 15,307 | -75% | -$6,361,805 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |